Comments on: SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024 https://insideout.vn/sys6002-crb-701-a-next-generation-nectin-4-targeting-antibody-drug-conjugate-continues-to-demonstrate-encouraging-safety-and-efficacy-observed-in-patients-with-nectin-4-positive-tumors-in-a-clinica/ Inside Out Sat, 01 Jun 2024 14:00:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2